Li-Ming Cheng Selected Research

Li-Ming Cheng Research Topics

Disease

3	Osteonecrosis (Kienbock's Disease) 01/2018 - 01/2008
2	COVID-19 01/2023 - 01/2021
2	Neoplasms (Cancer) 01/2020 - 01/2003
2	Pathologic Processes 09/2019 - 04/2018
1	Allergic Rhinitis 01/2022
1	Major Depressive Disorder (Major Depressive Disorders) 03/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Neuralgia (Stump Neuralgia) 01/2021
1	Hyperalgesia 01/2021
1	Central Nervous System Diseases (CNS Diseases) 08/2020
1	Spinal Cord Injuries (Spinal Cord Injury) 08/2020
1	Kidney Neoplasms (Kidney Cancer) 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2020
1	Myocardial Infarction 09/2019
1	Type 2 Diabetes Mellitus (MODY) 04/2018
1	Breast Neoplasms (Breast Cancer) 04/2018
1	Rheumatoid Arthritis 01/2018
1	Nephrosis 01/2018
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018
1	Osteoarthritis 11/2017
1	Spondylolisthesis 01/2017
1	Muscle Weakness 01/2017
1	Hemorrhage 02/2016
1	Necrosis 07/2015
1	Intervertebral Disc Degeneration 01/2015
1	Knee Osteoarthritis 10/2009
1	Femoral Neck Fractures 01/2008
1	Hepatocellular Carcinoma (Hepatoma) 01/2003

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2021
2	Sulfhydryl Compounds (Thiols)IBA 09/2019 - 04/2018
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018 - 01/2008
2	ElementsIBA 11/2017 - 01/2017
2	SteroidsIBA 07/2015 - 01/2008
1	Antiviral Agents (Antivirals)IBA 01/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023
1	Inactivated VaccinesIBA 01/2022
1	CurcuminIBA 03/2021
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 03/2021
1	Antidepressive Agents (Antidepressants)IBA 03/2021
1	HU 211 (HU 210)IBA 03/2021
1	CorticosteroneIBA 03/2021
1	Lipid NanoparticlesIBA 03/2021
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2021
1	SB 203580IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 01/2021
1	U 0126 (UO 126)IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	CytokinesIBA 01/2021
1	5-hydroxymethylcytosineIBA 01/2021
1	pyrazolanthroneIBA 01/2021
1	Mitogen-Activated Protein KinasesIBA 01/2021
1	IntegrinsIBA 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	IsotopesIBA 09/2019
1	xian ling gu baoIBA 01/2018
1	Hemoglobins (Hemoglobin)IBA 02/2016
1	RNA (Ribonucleic Acid)IBA 07/2015
1	Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA 01/2015
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2015
1	Proteins (Proteins, Gene)FDA Link 01/2003
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2003
1	TensinsIBA 01/2003
1	ParaffinIBA 01/2003

Therapy/Procedure

2	Knee Replacement Arthroplasty (Total Knee Replacement) 11/2017 - 10/2009
1	Intraperitoneal Injections 03/2021
1	Transplantation 08/2020
1	Combined Modality Therapy 08/2020
1	Therapeutics 08/2020
1	Computer-Assisted Surgery (Image Guided Surgery) 01/2020
1	Oral Administration 01/2018
1	Exercise Therapy (Therapy, Exercise) 01/2017
1	Blood Transfusion (Blood Transfusions) 02/2016
1	Osteotomy 10/2009